TY - JOUR
T1 - The influence of race on outcome following subarachnoid hemorrhage
AU - Zacharia, Brad E.
AU - Grobelny, Bartosz T.
AU - Komotar, Ricardo J.
AU - Sander Connolly, E.
AU - Mocco, J.
N1 - Funding Information:
J. Mocco thanks the Congress of Neurological Surgeons Wilder Penfield Fellowship for financial support.
PY - 2010/1
Y1 - 2010/1
N2 - The goal of this study was to examine the relationship between race and outcome following subarachnoid hemorrhage (SAH). We identified all SAH discharges in New York City during 2003. An adverse outcome was defined as in-hospital death or discharge other than to home. While correcting for age and gender, we examined the effect of race and payor status on outcome following SAH. Forty-four percent of patients with SAH were white. Being white had a significant relationship with outcome when controlled for payor status (odds ratio 0.56). Among self-pay/Medicaid patients, fewer white (52%) individuals suffered poor outcomes than non-white (66%, p = 0.03). Our results establish that white patients in New York City with SAH have better outcomes than non-whites. While it is unclear whether this discrepancy is secondary to pathophysiological differences or unidentified social factors, our findings demonstrate that this effect is independent of insurance status, and emphasize the need for further investigation into racial disparities in outcome following SAH.
AB - The goal of this study was to examine the relationship between race and outcome following subarachnoid hemorrhage (SAH). We identified all SAH discharges in New York City during 2003. An adverse outcome was defined as in-hospital death or discharge other than to home. While correcting for age and gender, we examined the effect of race and payor status on outcome following SAH. Forty-four percent of patients with SAH were white. Being white had a significant relationship with outcome when controlled for payor status (odds ratio 0.56). Among self-pay/Medicaid patients, fewer white (52%) individuals suffered poor outcomes than non-white (66%, p = 0.03). Our results establish that white patients in New York City with SAH have better outcomes than non-whites. While it is unclear whether this discrepancy is secondary to pathophysiological differences or unidentified social factors, our findings demonstrate that this effect is independent of insurance status, and emphasize the need for further investigation into racial disparities in outcome following SAH.
UR - http://www.scopus.com/inward/record.url?scp=72449159752&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=72449159752&partnerID=8YFLogxK
U2 - 10.1016/j.jocn.2009.05.015
DO - 10.1016/j.jocn.2009.05.015
M3 - Article
C2 - 20004103
AN - SCOPUS:72449159752
SN - 0967-5868
VL - 17
SP - 34
EP - 37
JO - Journal of Clinical Neuroscience
JF - Journal of Clinical Neuroscience
IS - 1
ER -